Items where authors include "Brunt, AM"

Article

Bundred, N, Porta, N, Brunt, AM et al. (20 more authors) (2022) Combined Perioperative Lapatinib and Trastuzumab in Early HER2-Positive Breast Cancer Identifies Early Responders: Randomized UK EPHOS-B Trial Long-Term Results. Clinical Cancer Research. ISSN 1078-0432

Schmid, P, Abraham, J, Chan, S et al. (26 more authors) (2020) Capivasertib Plus Paclitaxel Versus Placebo Plus Paclitaxel As First-Line Therapy for Metastatic Triple-Negative Breast Cancer: The PAKT Trial. Journal of Clinical Oncology, 38 (5). pp. 423-433. ISSN 0732-183X

Cameron, D, Morden, JP, Canney, P et al. (21 more authors) (2017) Accelerated versus standard epirubicin followed by cyclophosphamide, methotrexate, and fluorouracil or capecitabine as adjuvant therapy for breast cancer in the randomised UK TACT2 trial (CRUK/05/19): a multicentre, phase 3, open-label, randomised, controlled trial. The Lancet Oncology, 18 (7). pp. 929-945. ISSN 1470-2045

Pinhel, I, Hills, M, Drury, S et al. (27 more authors) (2012) ER and HER2 expression are positively correlated in HER2 non-overexpressing breast cancer. Breast Cancer Research, 14 (2). R46. ISSN 1465-5411